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LETTERS TO THE EDITORADVANTAGES OF THE
SEGMENTAL NONDIVIDED
INTERCOSTAL MUSCLE FLAP
To the Editor:
The intercostal muscle has been
increasingly used to protect and revas-
cularize bronchial stumps and anasto-
moses after pneumonectomy, sleeve
pneumonectomy, lung transplantation,
and bronchial sleeve resection.1 The
muscle can be mobilized with a gener-
ous flap of parietal pleura to increase
coverage. This flap allows protection
of the stump or anastomosis, early re-
vascularization of the bronchus,1 and
prevention of bronchopleural fistula
in case of dehiscence. The flap can be
easily prepared during thoracotomy,
before spreading the ribs, and left pos-
teriorly in the costovertebral groove
protected with a wet gauze during the
lung procedure. If not used, the flap
can be placed again between the ribs
while closing the thoracotomy. How-
ever, sometimes the need for this flap
cannot be anticipated preoperatively
(thus, if required, it has not been pre-
pared). Alternatively, a flap prepared
while opening the chest, as decided at
preoperative workup, would not be re-
quired because of intraoperative strat-
egy changes (eg, a simple lobectomy
instead of a sleeve resection or pneu-
monectomy, or an exploratory thora-
cotomy because of unexpected
metastatic disease or locally advanced
disease). In these situations, the sur-
geon would add operative time in pre-
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The Journala useless intercostal muscle deeply
crushed by the retractor at the thoracot-
omy site. The latter situation requires
mobilization of other flaps.
The segmental mobilization of an
intercostal muscle flap has been
described and repeatedly advocated
to decrease postoperative pain in
patients undergoing thoracotomy.2,3
This technique avoids crushing the in-
tercostal neurovascular bundle during
rib spreading with the retractor. Mobili-
zation from the rib is requiredonly at the
level where the retractor is placed and
takes only a few minutes, much less
than the full isolation of the muscle.
At the end of the procedure, the ribs
are approximated in the usual fashion
according to the surgeon’s preference.
This easy technique is extremely
useful to reduce postoperative pain
and to make the intercostal flap avail-
able in case of unexpected and compli-
cated surgical procedures. Also, if the
flap is not required as anticipated at
preoperative workup, the minimal seg-
mental mobilization allows easy clo-
sure of the chest without further
maneuvers and avoids having a ‘‘for-
eign body’’ in the posterior aspect of
the chest during the lung procedure.
This technique is now routinely used
at our center, speeding chest opening
and allowing bronchial protection
when required.
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THAT IS THE QUESTION
To the Editor:
We read with great interest the arti-
cle by Kuss and associates,1 who
aimed to systematically review all pro-
pensity score analyses comparing off-
and on-pump coronary artery bypass
grafting (CABG). Their meta-analysis
of 28 studies (100,066 patients) found
off-pump CABG superior to on-pump
CABG in short-term mortality, the
most valid criterion (odds ratio 0.69;
95% confidence interval [CI], 0.60–
0.75; P< .0001). Meanwhile, Møller
and collaborators’ meta-analysis2 of
57 randomized trials (5202 patients)
showed no significant difference in
mortality (relative risk [RR] 0.98;
95% CI, 0.66–1.44). In the future, the
largest ongoing randomized trial
(CORONARY trial, 4700 patients
planned, ClinicalTrials.gov Identifier:
NCT00463294) will contribute to the
definite answer, as stated by Kuss and
colleagues. Shroyer and coworkers3
recently reported the results of
another large randomized trial
(ROOBY trial, 2203 patients enrolled,
not included in Møller and associates’
meta-analysis). There was no signifi-
cant difference between off-pump and
on-pump CABG in the rate of death
from any cause before discharge or
within 30 days after the procedure (1.
6% vs 1.2%; RR 1.38; 95% CI, 0.
68–2.80; P ¼ .47). Furthermore, even
though this result of the ROOBY trial
is added to Møller and collaborators’
meta-analysis, there is no significant
difference in short-term mortality (RR
1.06; 95%CI, 0.67–1.67; P¼ .80; cal-
culated by us). The evidence from
randomized trials obviously demon-
strated equivalent short-term mortalityry c Volume 140, Number 2 485
Letters to the Editorbetween off-pump and on-pump
CABG, which is contradictory com-
pared with Kuss and colleagues’
results from nonrandomized studies.
Late mortality in off-pumpCABG is
another concern. In the meta-analysis
by Wijeysundera and coworkers,4
only 2 observational studies reporting
risk-adjusted effects on long-term
(1 year) outcomes showed essen-
tially no change inmortality (odds ratio
1.01; 95% CI, 0.74–1.40; P ¼ .93). In
the ROOBY trial,3 although no signif-
icant difference was found for the rate
of death from any cause within 1 year
(4.1% vs 2.9%; RR 1.41; 95% CI,
0.90–2.24; P ¼ .15), the rate of death
from cardiac causes within 1 year was
higher in the off-pump group than in
the on-pump group (2.7% vs 1.3%;
RR 2.05; 95% CI, 1.09–3.86; P ¼
.03). Our recent meta-analysis5 of 12
randomized trials (4326 patients en-
rolled) including the ROOBY trial
demonstrated a statistically significant
increase in late (1 year) all-cause
mortality by a factor of 1.37 with off-
pump relative to on-pump CABG
(RR 1.373; 95% CI, 1.043–1.808;
P ¼ .024).
Despite the superiority of off-pump
CABG to on-pump CABG in short-
term mortality found in Kuss and asso-
ciates’ meta-analysis1 of propensity
score analyses, on-pump rather than
off-pump CABG should be considered
at least for patients who meet the crite-
ria for enrollment in randomized trials
(typically for low- to moderate-risk
patients) because late, not short-term,
mortality reduction must imply the
greatest clinical benefit among patients
undergoing CABG.
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We thank Takagi and Umemoto1
for their interest in our recent system-
atic review of propensity score (PS)
analyses in off-pump versus on-pump
coronary artery bypass grafting.2 As
Takagi and Umemoto correctly point
out, our estimate for the effect of off-
pump coronary artery bypass grafting
on short-term mortality (odds ratio
[OR], 0.69; 95% confidence interval
[CI], 0.60–0.75) differs from the corre-
sponding estimate from randomized
controlled trials (RCTs). In their large
meta-analysis, Møller and colleagues3
found a relative risk of 0.98 (95% CI,
0.66–1.44). Takagi and Umemoto1
calculated a relative risk of 1.06
(95% CI, 0.67–1.67) by adding the re-
sults of the ROOBY trial4 to Møller
and colleagues’ results.
Setting aside the subtlety of equat-
ing ORs with relative risks, we would
like to point out 2 facts. First, even after
including the ROOBY results to the
data of Møller and colleagues,3 the CI
for the effect still includes our PS effect
estimate of 0.69. That means that even
data from nearly 100 randomized trials
on the off-pump/on-pump issue still
leave considerable uncertainty (as re-
flected by the large CI) on the size of
the true effect. In particular, ware still
far from achieving equivalent short-ardiovascular Surgery c August 2010term mortality, which Takagi and
Umemoto1 deduce from the current
data. This lack of information is also
emphasized byMøller and colleagues3
in their trial sequential analysis: The
authors state that demonstrating equiv-
alence or a minimal clinically relevant
effect of the off-pump technique on
mortality would require more than
240,000 patients.
Second, and this is also pointed out
correctly by Takagi and Umemoto,1
we do not expect the effect estimates
from PS analyses and RCTs to be
equal because the underlying study
populations usually differ. Patients in
RCTs are, in general, younger and
healthier than the average patient. In
a study currently under review, we re-
viewed 28 PS analyses and 51 RCTs
that compared off-pump and on-
pump coronary artery bypass graft-
ing.5 We found an average age of
65.8 years and an average left ventric-
ular ejection fraction of 58.8% in the
PS analyses, compared with an aver-
age age of 63.1 years and a mean left
ventricular ejection fraction of 62.7%
in the RCTs, confirming that patients
in the PS analyses are older and in
poorer health. After generating similar
study populations from PS analyses
and RCTs by a meta-matching algo-
rithm (resulting in a meta-matched
sample of 10 PS analyses and 29
RCTs), we found an OR for short-
term mortality of 0.53 (95% CI,
0.43–0.66) in the PS analyses and
0.58 (95% CI, 0.24–1.39) from the
RCTs, resulting in an OR difference
of0.05 (95% CI,0.56 to 0.47). Un-
fortunately, this difference is also as-
sociated with a large CI, but there is
some evidence (supported by other
clinical outcome data not shown) that
the treatments effects are similar, pro-
vided the underlying populations in
PS analyses and RCTs are similar.
Finally, we completely agree with
Takagi and Umemoto1 on the impor-
tance of long-termmortality. Sufficient
long-term mortality figures were avail-
able in 7 PS analyses in our data set,
initially accounting for 6813 patients.
